Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) EPS (Basic) (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of EPS (Basic) data on record, last reported at $9.49 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 488.96% year-over-year to $9.49; the TTM value through Dec 2025 reached $4.45, up 282.39%, while the annual FY2025 figure was -$3.22, 69.79% up from the prior year.
  • EPS (Basic) reached $9.49 in Q4 2025 per CAI's latest filing, up from $0.09 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $9.49 in Q4 2025 and bottomed at -$10.27 in Q2 2025.